期刊
ACS INFECTIOUS DISEASES
卷 6, 期 11, 页码 2830-2843出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00353
关键词
American trypanosomiasis; Chagas disease; chemotherapy; drug discovery; neglected tropical disease; screening cascade; target product profile; Trypanosoma cruzi
资金
- FPU Grant [FPU14/01537]
- Ministry of Education of Spain
Chagas disease is a neglected tropical disease and a global public health issue. In terms of treatment, no progress has been made since the 1960s, when benznidazole and nifurtimox, two obsolete drugs still prescribed, were used to treat this disease. Hence, currently, there are no effective treatments available to tackle Chagas disease. Over the past 20 years, there has been an increasing interest in the disease. However, parasite genetic diversity, drug resistance, tropism, and complex life cycle, along with the limited understanding of the disease and inadequate methodologies and strategies, have resulted in the absence of new insights in drugs development and disappointing outcomes in clinical trials so far. In summary, new drugs are urgently needed. This Review considers the relevant aspects related to the lack of drugs for Chagas disease, resumes the advances in tools for drug discovery, and discusses the main features to be taken into account to develop new effective drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据